| Variation | | Type (Consequence) | Condition | Classification, Review status |
---|
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | Cardiovascular phenotype | |
| | DNASE1L1, LOC130068869 +1 more (V5L) | Single nucleotide variant (missense variant +2 more) | 3-Methylglutaconic aciduria type 2 +3 more | |
| | TAFAZZIN, DNASE1L1 +1 more (F9L) | Single nucleotide variant (missense variant +2 more) | 3-Methylglutaconic aciduria type 2 +1 more | |
| | DNASE1L1, LOC130068869 +1 more (P13S) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +1 more | |
| | TAFAZZIN, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | not specified +2 more | |
| | TAFAZZIN, DNASE1L1 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | Cardiovascular phenotype | |
| | DNASE1L1, LOC130068869 +1 more (V23I) | Single nucleotide variant (5 prime UTR variant +2 more) | Cardiovascular phenotype | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 +2 more | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 +2 more | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 +1 more | |
Click to view in NCBI Gene